| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2026―May―06 |
Prevalence of innate immunity gene variants rs5743708, rs3853839, and rs8177374 in patients hospitalized in 2021 with a diagnosis of COVID-19 |
S. V. Mikhailova, M. Yu. Moskvina, D. E. Ivanoshchuk, O. P. Khripko, P. S. Orlov, D. V. Denisova, et al. (+2) P. A. Shesternya, M. I. Voevoda |
| 2 |
[GO] |
2026―Feb―05 |
The role of oxidative stress in COVID-19 pathogenesis |
Yu. V. Bykov |
| 3 |
[GO] |
2026―Feb―05 |
On the impact of the COVID-19 pandemic on the мanifestations of aging |
O. N. Ergashev, U. R. Saginbaev, I. M. Kobelev |
| 4 |
[GO] |
2026―Feb―05 |
Epidemiologic evaluation of vaccination efficacy during different periods of COVID-19 epidemic |
V. S. Zaguzov, L. V. Lyalina, V. V. Vetrov, Zh. R. Molchanova, G. V. Chugunova, A. B. Revenko, et al. (+2) M. B. Petukhova, E. L. Kalinina |
| 5 |
[GO] |
2025―Sep―06 |
Histological changes in the lungs and viral load indicators of guinea pigs in a model of SARS-CoV-2 infection |
A. V. Shipovalov, G. A. Kudrov, E. K. Ivleva, V. V. Omigov, O. V. Pyankov, A. V. Zaykovskaya, et al. (+6) S. A. Bodnev, I. S. Shulgina, S. V. Savchenko, V. A. Gritsinger, O. S. Taranov, S. V. Aidagulova |
| 6 |
[GO] |
2025―Jan―08 |
Risk assessment of hypertensive and metabolic disorders in pregnant women with COVID-19 |
I. V. Zhukovets, I. A. Andrievskaya, N. A. Krivoshchekova, A. N. Narkevich, E. M. Ustinov |
| 7 |
[GO] |
2024―Nov―01 |
Features of lipid metabolism and hemostasis in patients with arterial hypertension underwent a new coronavirus infection COVID-19 |
E. V. Sevostyanova, Yu. A. Nikolaev, V. Ya. Polyakov, I. L. Emelyanova |
| 8 |
[GO] |
2024―Sep―02 |
To the question of thrombotic and hemorrhagic complications in patients with COVID-19 |
N. I. Glushkov, P. D. Puzdriak, A. N. Zvyagintseva, E. I. Panasyuk, V. Yu. Gavrilov, M. A. Ivanov, K. V. Zhdanovich |
| 9 |
[GO] |
2024―Sep―02 |
Features of gender, age, social factors and polymorbidity in patients, undergone COVID-19 |
Yu. A. Nikolaev, E. V. Sevostyanova, I. M. Mitrofanov, V. Ya. Polyakov |
| 10 |
[GO] |
2024―Sep―02 |
COVID-19 and pregnancy: impact, outcomes, and potential therapy |
V. I. Shcherbakov, T. I. Ryabichenko, O. O. Obukhova, T. V. Kartseva, V. E. Menshchikova, D. V. Eliseeva, M. I. Voevoda |
| 11 |
[GO] |
2024―Sep―02 |
Features of the impact of the COVID-19 pandemic on the prevalence of certain respiratory diseases of infections etiology |
I. A. Sorokin, M. V. Nikolskaya, V. L. Melnikov |
| 12 |
[GO] |
2024―Mar―07 |
COVID-19 and multiple sclerosis: is there a connection? |
I. E. Arkhipov, A. I. Prokaeva, A. V. Zateev, V. K. Kozyreva, D. S. Korobko, N. A. Malkova |
| 13 |
[GO] |
2024―Jan―12 |
Efficacy of stage I rehabilitation of medical workers with moderate course of interstitial lung damage associated with COVID-19 |
L. A. Shpagina, V. A. Drobyshev, S. A. Karmanovskaya, E. M. Loktin, I. S. Shpagin, O. S. Kotova, et al. (+3) L. A. Panacheva, T. V. Musienko, E. A. Zaikina |
| 14 |
[GO] |
2023―Oct―31 |
Features of natural population movement in the Siberian Federal District during the coronavirus pandemic |
M. I. Voevoda, V. M. Chernyshev, I. F. Mingazov |
| 15 |
[GO] |
2023―Sep―01 |
Predictors of an unfavorable course of COVID-19 |
V. Ya. Polyakov, Yu. A. Nikolaev, Zh. A. Garina, I. M. Mitrofanov, E. V. Sevostyanova |
| 16 |
[GO] |
2023―Sep―01 |
Mechanisms of renal damage in patients with new coronavirus infection (literature review) |
E. V. Utkina, V. V. Novakovskaya, M. V. Egorova, N. V. Fomina, L. D. Chesnokova |
| 17 |
[GO] |
2023―Apr―28 |
The quality of medical care in a round-the-clock hospital during the COVID-19 pandemic |
E. V. Usacheva, O. M. Kulikova, P. E. Svechkar, M. V. Semenikhina |
| 18 |
[GO] |
2023―Apr―28 |
Pneumomediastinum as a predictor of negative prognosis in patients with coronavirus pneumonia |
Yu. S. Kuznetsov, V. M. Durleshter, V. A. Pshukov, V. V. Markin, А. А. Kryachko, S. V. Shchyplyak, et al. (+2) D. S. Murashko, V. A. Rudko |
| 19 |
[GO] |
2022―Oct―27 |
Features of laboratory parameters in children with multisystem inflammatory syndrome associated with SARS-CoV-2 |
O. O. Obukhova, T. I. Ryabichenko, G. S. Karpovich, G. A. Skosyreva, I. V. Kuimova, M. I. Voevoda |
| 20 |
[GO] |
2022―Feb―21 |
Metabolic disorders and the risk of COVID-19 |
A. A. Karaseva, A. D. Khudyakova, Yu. I. Ragino |
| 21 |
[GO] |
2022―Feb―02 |
Non-alcoholic fatty liver disease and metabolic liver dysfunction in the new coronavirus infection COVID-19 |
A. A. Karaseva, N. E. Evdokimova, A. D. Khudyakova, E. V. Striukova, M. V. Volkova, I. I. Logvinenko |
| 22 |
[GO] |
2022―Feb―02 |
Prospects for the use of nanostructured silver preparations for the control of infections diseases, including COVID-19 |
V. A. Burmistrov, N. E. Bogdanchikova, A. O. Gyusan, B. B. Uraskulova, H. Almanza-Reyes, M. Alvаrado-Vera, et al. (+4) I. Plascencia-Lopez, A. N. Pestryakov, L. N. Rachkovskaya, A. Yu. Letyagin |
| 23 |
[GO] |
2022―Feb―02 |
On the state of public health and healthcare Siberian Federal District during the pandemic (some results of 2020) |
V. M. Chernyshev, M. I. Voevoda, O. V. Strelchenko, L. S. Shalygina, I. F. Mingazov |
